Related Experiment Video
Updated: Oct 26, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Known and Unknown Transboundary Infectious Diseases as Hybrid Threats
1Orion Integrated Biosciences Inc., Manhattan, KS, United States.
Abstract:
The pathogenicity, transmissibility, environmental stability, and potential for genetic manipulation make microbes hybrid threats that could blur the distinction between peace and war. These agents can fall below the detection, attribution, and response capabilities of a nation and seriously affect their health, trade, and security. A framework that could enhance horizon scanning regarding the potential risk of microbes used as hybrid threats requires not only accurately discriminating known and unknown pathogens but building novel scenarios to deploy mitigation strategies. This demands the transition of analyst-based biosurveillance tracking a narrow set of pathogens toward an autonomous biosurveillance enterprise capable of processing vast data streams beyond human cognitive capabilities. Autonomous surveillance systems must gather, integrate, analyze, and visualize billions of data points from different and unrelated sources. Machine learning and artificial intelligence algorithms can contextualize capability information for different stakeholders at different levels of resolution: strategic and tactical. This document provides a discussion of the use of microorganisms as hybrid threats and considerations to quantitatively estimate their risk to ensure societal awareness, preparedness, mitigation, and resilience.
Insights
Microbes pose hybrid threats, impacting national security and health. Autonomous biosurveillance using AI is crucial for detecting and mitigating these risks effectively.
Area of Science:
- Microbiology
- Biosecurity
- National Security
Background:
- Microorganisms are increasingly recognized as hybrid threats due to their pathogenicity, transmissibility, and potential for genetic manipulation.
- These agents can evade current detection, attribution, and response capabilities, posing significant risks to national health, trade, and security.
- Existing biosurveillance methods are limited in scope and struggle to address the complexity of novel microbial threats.
Purpose of the Study:
- To discuss the use of microorganisms as hybrid threats.
- To propose a framework for enhanced horizon scanning and risk assessment of microbial hybrid threats.
- To advocate for the transition towards autonomous biosurveillance systems.
Main Methods:
- Conceptual framework development for microbial hybrid threat risk assessment.
- Discussion of machine learning (ML) and artificial intelligence (AI) applications in autonomous biosurveillance.
- Integration of diverse data streams for comprehensive threat analysis.
Main Results:
- Autonomous biosurveillance systems can process vast data streams beyond human cognitive limits.
- ML and AI algorithms can contextualize threat information for strategic and tactical stakeholders.
- A quantitative risk estimation approach is essential for societal preparedness and resilience.
Conclusions:
- Microbial hybrid threats necessitate advanced, autonomous biosurveillance capabilities.
- AI and ML are key enablers for effective detection, attribution, and response to these threats.
- Societal awareness, preparedness, and resilience are paramount in mitigating the risks posed by microbial hybrid threats.
More Related Videos
Related Concept Videos
Viral Recombination
Hybrid Zones
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Vaccinations
Horizontal Gene Transfer
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

